Mitsubishi Tanabe's Japan diabetes alliance reflects competitive market
This article was originally published in Scrip
Executive Summary
Mitsubishi Tanabe Pharma (MTP) is tapping into the sales power of Daiichi Sankyo in Japan, tying up with its larger peer for the co-marketing of two pipeline oral therapies for type 2 diabetes.